Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlo Heirman

Showing results (11-20 of 80) with videos related to

Pageof 8
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|February 7, 2004
Identification of new antigenic peptide presented by HLA-Cw7 and encoded by several MAGE genes using dendritic cells transduced with lentivirusesKarine Breckpot, Carlo Heirman, Catherine De Greef, et al.
Methods in Molecular Biology (Clifton, N.J.)|April 14, 2010
Immunotherapy of cancer with dendritic cells loaded with tumor antigens and activated through mRNA electroporationAn M T Van Nuffel, Jurgen Corthals, Bart Neyns, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 7, 2009
Attenuated expression of A20 markedly increases the efficacy of double-stranded RNA-activated dendritic cells as an anti-cancer vaccineKarine Breckpot, Cindy Aerts-Toegaert, Carlo Heirman, et al.
Cancer Research|September 23, 2003
Efficient presentation of known HLA class II-restricted MAGE-A3 epitopes by dendritic cells electroporated with messenger RNA encoding an invariant chain with genetic exchange of class II-associated invariant chain peptideAude Bonehill, Carlo Heirman, Sandra Tuyaerts, et al.
Journal of Leukocyte Biology|July 23, 2005
Dendritic cells differentiated in the presence of IFN-{beta} and IL-3 are potent inducers of an antigen-specific CD8+ T cell responseKarine Breckpot, Jurgen Corthals, Aude Bonehill, et al.
Human Gene Therapy|November 12, 2009
Lumenal part of the DC-LAMP protein is not required for induction of antigen-specific T cell responses by means of antigen-DC-LAMP messenger RNA-electroporated dendritic cellsBrenda De Keersmaecker, Carlo Heirman, Sabine Allard, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 26, 2014
The potential of antigen and TriMix sonoporation using mRNA-loaded microbubbles for ultrasound-triggered cancer immunotherapyHeleen Dewitte, Sandra Van Lint, Carlo Heirman, et al.
Cancer Immunology, Immunotherapy : CII|May 16, 2007
Current approaches in dendritic cell generation and future implications for cancer immunotherapySandra Tuyaerts, Joeri L Aerts, Jurgen Corthals, et al.
Human Gene Therapy|June 24, 2004
Activation of monocytes via the CD14 receptor leads to the enhanced lentiviral transduction of immature dendritic cellsKarine Breckpot, Jurgen Corthals, Carlo Heirman, et al.
Expert Review of Vaccines|September 30, 2014
The ReNAissanCe of mRNA-based cancer therapySandra Van Lint, Dries Renmans, Katrijn Broos, et al.
Pageof 8

Showing results (11-20 of 80) with videos related to

Sort By:
Pageof 8
Journal of Immunology (Baltimore, Md. : 1950)|February 7, 2004
Identification of new antigenic peptide presented by HLA-Cw7 and encoded by several MAGE genes using dendritic cells transduced with lentivirusesKarine Breckpot, Carlo Heirman, Catherine De Greef, et al.
Methods in Molecular Biology (Clifton, N.J.)|April 14, 2010
Immunotherapy of cancer with dendritic cells loaded with tumor antigens and activated through mRNA electroporationAn M T Van Nuffel, Jurgen Corthals, Bart Neyns, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 7, 2009
Attenuated expression of A20 markedly increases the efficacy of double-stranded RNA-activated dendritic cells as an anti-cancer vaccineKarine Breckpot, Cindy Aerts-Toegaert, Carlo Heirman, et al.
Cancer Research|September 23, 2003
Efficient presentation of known HLA class II-restricted MAGE-A3 epitopes by dendritic cells electroporated with messenger RNA encoding an invariant chain with genetic exchange of class II-associated invariant chain peptideAude Bonehill, Carlo Heirman, Sandra Tuyaerts, et al.
Journal of Leukocyte Biology|July 23, 2005
Dendritic cells differentiated in the presence of IFN-{beta} and IL-3 are potent inducers of an antigen-specific CD8+ T cell responseKarine Breckpot, Jurgen Corthals, Aude Bonehill, et al.
Human Gene Therapy|November 12, 2009
Lumenal part of the DC-LAMP protein is not required for induction of antigen-specific T cell responses by means of antigen-DC-LAMP messenger RNA-electroporated dendritic cellsBrenda De Keersmaecker, Carlo Heirman, Sabine Allard, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 26, 2014
The potential of antigen and TriMix sonoporation using mRNA-loaded microbubbles for ultrasound-triggered cancer immunotherapyHeleen Dewitte, Sandra Van Lint, Carlo Heirman, et al.
Cancer Immunology, Immunotherapy : CII|May 16, 2007
Current approaches in dendritic cell generation and future implications for cancer immunotherapySandra Tuyaerts, Joeri L Aerts, Jurgen Corthals, et al.
Human Gene Therapy|June 24, 2004
Activation of monocytes via the CD14 receptor leads to the enhanced lentiviral transduction of immature dendritic cellsKarine Breckpot, Jurgen Corthals, Carlo Heirman, et al.
Expert Review of Vaccines|September 30, 2014
The ReNAissanCe of mRNA-based cancer therapySandra Van Lint, Dries Renmans, Katrijn Broos, et al.
Pageof 8